BMY241129C57000
- 2.16
- 0.000.00%
Bristol-Myers Squibb Newsroom
PPBT Stock Surges 150% on Superior Efficacy of PDAC Combo Therapy
Tuesday S&P 500 Pulls Back From Highs, Nasdaq Climbs | Live Stock
AI Proteins Announces Research Collaboration and Option Agreement With Bristol Myers Squibb for Miniprotein-Based Therapeutics Valued up to $400M
Bristol-Myers Squibb To Present At Citi's 2024 Global Healthcare Conference; Webcast At 8:00 AM ET
Bristol-Myers Squibb Company (BMY): Close to Becoming a Dividend Aristocrat
S&P 500 and Nasdaq Hit Closing and Trading Highs Monday | Wall Street Today
Big Pharma Pushes To Revise Biden-era Medicare Drug Price Negotiation Law Under Trump
December Starts With a Mixed Market | Live Stock
Ovarian Cancer Therapeutics Business Research Report 2024-2030, Profiles of 12 Players Including Amgen, AstraZeneca, and Bristol-Myers Squibb Company
Is Bristol-Myers Squibb Stock a Millionaire Maker?
Catalyst Watch: November Jobs, OPEC+ Meeting, Marvell, Salesforce Earnings
Wednesday Ends With Index Decline | Wall Street Today
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
Trump Taps Jay Bhattacharya to Lead National Institutes of Health
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
Bristol Myers Squibb to Participate in Citi's 2024 Global Healthcare Conference
Bristol-Myers Squibb Hits 14-month High
Merck Phase 3 Study of Winrevair in PAH Meets Primary Endpoint
S&P 500, Dow Hit Records Right After Open | Live Stock